90 related articles for article (PubMed ID: 16416875)
21. Pdx-1 modulates histone H4 acetylation and insulin gene expression in terminally differentiated alpha-TC-1 cells.
Wang HW; Breslin MB; Lan MS
Pancreas; 2007 Mar; 34(2):248-53. PubMed ID: 17312465
[TBL] [Abstract][Full Text] [Related]
22. Changes in islet microvasculature following streptozotocin-induced beta-cell loss and subsequent replacement in the neonatal rat.
Nicholson JM; Arany EJ; Hill DJ
Exp Biol Med (Maywood); 2010 Feb; 235(2):189-98. PubMed ID: 20404034
[TBL] [Abstract][Full Text] [Related]
23. How to make pancreatic beta cells--prospects for cell therapy in diabetes.
Nir T; Dor Y
Curr Opin Biotechnol; 2005 Oct; 16(5):524-9. PubMed ID: 16084716
[TBL] [Abstract][Full Text] [Related]
24. Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1.
Chen S; Ding J; Yu C; Yang B; Wood DR; Grayburn PA
Gene Ther; 2007 Jul; 14(14):1102-10. PubMed ID: 17460716
[TBL] [Abstract][Full Text] [Related]
25. [Therapeutic angiogenesis for ischemic diseases].
Aoki M; Morishita R
Nihon Rinsho; 2006 Apr; 64(4):762-8. PubMed ID: 16613196
[TBL] [Abstract][Full Text] [Related]
26. Enhanced cytotoxicity of RIPTK gene therapy of pancreatic cancer via PDX-1 co-delivery.
Liu S; Wang XP; Brunicardi FC
J Surg Res; 2007 Jan; 137(1):1-9. PubMed ID: 17161985
[TBL] [Abstract][Full Text] [Related]
27. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
Deuse T; Peter C; Fedak PW; Doyle T; Reichenspurner H; Zimmermann WH; Eschenhagen T; Stein W; Wu JC; Robbins RC; Schrepfer S
Circulation; 2009 Sep; 120(11 Suppl):S247-54. PubMed ID: 19752375
[TBL] [Abstract][Full Text] [Related]
28. [Pax4, islet plasticity and diabetes].
Brun T; Wollheim CB; Gauthier BR
Med Sci (Paris); 2005 Apr; 21(4):358-9. PubMed ID: 15811298
[No Abstract] [Full Text] [Related]
29. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro.
Moriscot C; de Fraipont F; Richard MJ; Marchand M; Savatier P; Bosco D; Favrot M; Benhamou PY
Stem Cells; 2005 Apr; 23(4):594-603. PubMed ID: 15790780
[TBL] [Abstract][Full Text] [Related]
30. Neonatal diabetes mellitus: A rare but important diagnosis in the critically ill infant.
Woolley SL; Saranga S
Eur J Emerg Med; 2006 Dec; 13(6):349-51. PubMed ID: 17091057
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease.
Yang ZJ; Xu SL; Chen B; Zhang SL; Zhang YL; Wei W; Ma DC; Wang LS; Zhu TB; Li CJ; Wang H; Cao KJ; Gao W; Huang J; Ma WZ; Wu ZZ
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):790-6. PubMed ID: 19215239
[TBL] [Abstract][Full Text] [Related]
32. An infant with combination gene mutations for Monogenic Diabetes of Youth (MODY) 2 and 4, presenting with Diabetes Mellitus Requiring Insulin (DMRI) at 8 months of age.
Odem J; Munzinger E; Violand S; Van Morlan A; Rife D; Bachrach B
Pediatr Diabetes; 2009 Dec; 10(8):550-3. PubMed ID: 19515026
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous transfer of vascular endothelial growth factor and hepatocyte growth factor genes effectively promotes liver regeneration after hepatectomy in cirrhotic rats.
Oe H; Kaido T; Furuyama H; Mori A; Imamura M
Hepatogastroenterology; 2004; 51(60):1641-7. PubMed ID: 15532795
[TBL] [Abstract][Full Text] [Related]
34. [Gene therapy for peripheral arterial diseases in diabetes mellitus].
Makino H; Ogihara T; Morishita R
Nihon Rinsho; 2002 Oct; 60 Suppl 10():449-56. PubMed ID: 12430268
[No Abstract] [Full Text] [Related]
35. [Gene therapy for respiratory tract infection].
Yanagihara K
Nihon Rinsho; 2005 Dec; 63 Suppl 12():617-21. PubMed ID: 16416862
[No Abstract] [Full Text] [Related]
36. [Is a gene therapy for diabetic syndromes foreseeable?].
Assan R; Clauser E; Larger E
Diabete Metab; 1994; 20(2 Pt 2):240-50. PubMed ID: 8001711
[TBL] [Abstract][Full Text] [Related]
37. Prospects for gene therapy of diabetes mellitus.
Welsh N
Gene Ther; 2000 Feb; 7(3):181-2. PubMed ID: 10694793
[No Abstract] [Full Text] [Related]
38. Inability to process and store proinsulin in transdifferentiated pancreatic acinar cells lacking the regulated secretory pathway.
Aldibbiat A; Marriott CE; Scougall KT; Campbell SC; Huang GC; Macfarlane WM; Shaw JA
J Endocrinol; 2008 Jan; 196(1):33-43. PubMed ID: 18180315
[TBL] [Abstract][Full Text] [Related]
39. Identification of a single nucleotide insertion polymorphism in the upstream region of the insulin promoter factor-1 gene: an association study with diabetes mellitus.
Yamada K; Yuan X; Ishiyama S; Ichikawa F; Kohno S; Shoji S; Hayashi H; Nonaka K
Diabetologia; 1998 May; 41(5):603-5. PubMed ID: 9628281
[TBL] [Abstract][Full Text] [Related]
40. A newly identified mutation in an IPF1 binding site of the insulin gene promoter may predispose to type 2 diabetes mellitus.
Malecki MT; Lebrun P; Pezzolesi M; Warram JH; Krolewski AS; Jhala US
Diabetologia; 2006 Aug; 49(8):1985-7. PubMed ID: 16741735
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
